Skip Navigation Skip to Content Skip to Footer

Professor Christopher Conlon

MA, MD, FRCP

Chris Conlon is an Honorary Consultant Physician in Infectious Diseases in Oxford and Professor of Infectious Diseases at Oxford University.

He trained in Oxford, London and Birmingham and spent 3 years working in Africa in Zimbabwe and Zambia. His main interests are HIV, TB, Travel Medicine and COVID.

Chris is a past Chair of the Joint Specialty Committee on Infection and Tropical Medicine at the Royal College of Physicians and past Secretary of the British Infection Society. He served on the Expert Advisory Group on AIDS and is currently on the UK Advisory Panel for Healthcare Workers Infected with Bloodborne Viruses, and the Travel Subcommittee of the Joint Committee on Vaccines and Immunisations. He is Chair of the Tropical Medicine Group in the Nuffield Department of Medicine and is one of the senior editors for the 6th edition of the Oxford Textbook of Medicine.

Selected Publications

SPARTAC trial investigators, Fidler S, Porter K et al. Short-course antiretroviral therapy in primary HIV infection. New England Journal of Medicine 2013; 368: 207-217.

Walker TM, Lalor MK, Broda A, Saldana-Ortega L, Morgan M, Parker L,, Churchill S, Bennett K, Gulobchik T, Giess AP, Del Ojo Elias C, Jeffery KJ, Bowler IC, Laurenson IF, Barrett A, Drobniewski F, McCarthy ND, Anderson LF, Abubakar I, Thomas HL, Monk P, Smith EG, Walker AS, Crook DW, Peto TE, Conlon CP. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK 2007-2012 with whole pathogen genome sequences: an observational study. Lancet Respiratory Medicine 2014; 2: 285-292.

Whitworth HS, Badhan A, Boakye AA, Takwoingi Y, Rees-Roberts M, Partlett C, Lambie H, Innes J, Cooke G, Lipman M, Conlon C, Macallan D, Chua F, Post FA, Wiselka M, Woltmann G, Deeks JJ, Kon OM, Lalvani A; Interferon-Release Assays for Diagnostic Evaluation of Active Tuberculosis Study Group. Clinical utility of existing and second-generation interferon-release assays for diagnostic evaluation of tuberculosis: an observational study. Lancet Infectious Diseases 2019, 19: 193-202.

Chen B, Jiang C, Han B, Guan C, Fang G, Yan S, Wang K, Liu L, Conlon CP, Xie R, Song R. High prevalence of occult thrombosis in cases of mild/moderate COVID-19. International Journal of Infectious Diseases 2020, 104; 77-82.

Lumley SF, O’Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, Marsden BD, Cox S, James T, Warren F, Peck LJ, Ritter TG, de Toledo Z, Warren L, Axten D, Cornall RJ, Jones EY, Stuart DI, Screaton G, Ebner D, Hoosdally S, Chand M, Crook DW, O’Donnell AM, Conlon CP, Pouwels KB, Walker AS, Peto TEA, Hopkins S, Walker TM, Jeffery K, Eyre DW; Oxford University Hospitals Staff Testing Group. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. New England Journal of Medicine 2021, 384; 533-540.